查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1754184

人工生命器官和医疗仿生市场报告（按产品类型（人工生命器官、医疗仿生学）、应用（医院、诊所等）和地区）2025 年至 2033 年

Artificial Vital Organs and Medical Bionics Market Report by Product Type (Artificial Vital Organs, Medical Bionics), Application (Hospitals, Clinics, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球人工重要器官和医疗仿生市场规模达492亿美元。展望未来， IMARC Group预计到2033年，市场规模将达到745亿美元，2025-2033年期间的复合年增长率（CAGR）为4.48%。呼吸系统疾病、肝硬化、心臟和肝衰竭盛行率的上升，易患器官疾病的老年人口的增加，以及各种技术进步，是推动市场发展的一些关键因素。

人工重要器官，通常被称为人造器官或生物人工器官，是旨在模拟人体自然器官功能的人造装置。这些装置旨在临时或永久取代功能失常或衰竭的生物器官，帮助患者维持基本身体功能，在某些情况下甚至增强其功能。另一方面，医学仿生学是医学科学与工程的一个领域，专注于开发和整合生物和人工组件，以恢復或增强人体功能。

目前，各种疾病的发生率显着上升，包括呼吸系统疾病、肝硬化以及心臟、肾臟和肝衰竭。这种激增与医疗保健产业的扩张密切相关，并成为市场成长的重要催化剂。此外，全球范围内老年人口的不断增长，尤其容易患上器官相关疾病，这也对市场扩张做出了重大贡献。此外，功能齐全的人工心臟、肝臟、肺、尿道、气管和肾臟等创新产品的不断发展，正在对市场动态产生积极的影响。此外，主要的市场参与者正在大力投资研发 (R&D) 工作，旨在引入透过工程组织进行器官再生的尖端方法。这种持续的创新正在为市场培育光明的前景。此外，随着生物人工器官的出现，对人工器官的需求也不断增长，这些器官可以提高存活率并加快患者康復速度。这种不断增长的需求因移植桥樑和危重医疗病例復健桥樑等救生技术的实施而进一步推动，进一步促进了市场成长。

人工生命器官与医疗仿生市场趋势/驱动因素：

呼吸系统疾病、肝硬化和器官衰竭盛行率上升

慢性阻塞性肺病 (COPD) 和肺部感染等呼吸系统疾病的发生率显着上升。患有严重呼吸系统疾病的患者通常需要人工肺部或其他辅助设备才能充分呼吸。此外，由于过量饮酒、病毒性肝炎感染和非酒精性脂肪肝等各种因素，包括肝硬化在内的肝病发生率也呈现上升趋势。晚期肝硬化患者可能需要肝臟移植，而人工肝臟可以作为肝臟移植的过渡治疗，甚至是长期解决方案。此外，心臟和肝衰竭是全球范围内的重大健康问题。由于人口老化、肥胖和生活方式选择等因素，充血性心臟衰竭和末期肝病等疾病的发生率正在上升。人工心臟和肝臟支持系统在患者等待移植期间或作为永久性支持方案时，在提供挽救生命的解决方案方面发挥着至关重要的作用。

全球老年人口不断增加

全球人口结构正朝向老化转变。由于自然老化过程，老年人更容易患上器官疾病，因此他们成为人工重要器官干预的关键人群。此外，老年人更容易罹患慢性疾病，包括心血管疾病、呼吸系统疾病和肾臟疾病。这些疾病通常需要人工心臟、人工肺或人工肾臟等干预措施来管理或改善患者的生活品质。起搏器和人工耳蜗等医疗仿生技术也常用于老年人，以解决与年龄相关的健康问题。人工重要器官和医疗仿生技术对于延长和改善老年人的寿命至关重要，使他们能够在晚年享受更高品质的生活。

各种技术进步

医疗技术的进步显着提升了人工重要器官和医学仿生学的设计、功能和有效性。此外，功能齐全的人工器官（例如人工心臟和人工肺）也得到了开发，其功能得到了增强，使患者能够过上更积极的生活。此外，尖端材料与生物工程技术的融合，催生了与自然器官高度相似的生物人工器官，从而降低了排斥风险并改善了患者的整体治疗效果。此外，医疗科技产业的领导者正在大力投资旨在改善人工重要器官和医学仿生学的研发活动。这些投资促进了更精密的设备、更先进的材料和更先进的手术技术的开发，所有这些都有助于改善患者的治疗效果。

本报告回答的关键问题

  • 人工生命器官和医疗仿生市场有多大？ 2025-2033年全球人工生命器官和医疗仿生市场的预期成长率是多少？
  • 推动全球人工生命器官和医疗仿生市场发展的关键因素有哪些？
  • COVID-19 对全球人工生命器官和医疗仿生市场有何影响？
  • 根据产品类型，全球人工生命器官和医疗仿生市场是如何分布的？
  • 全球人工生命器官和医疗仿生学市场的重点区域有哪些？
  • 全球人工生命器官和医疗仿生学市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球人工生命器官与医疗仿生市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 人工重要器官
    • 关键部分
      • 人工肝臟
      • 人工心臟
      • 人工胰臟
      • 人工肾臟
      • 人工肺
      • 氧合器
  • 医疗仿生学
    • 关键部分
      • 仿生肢体
      • 视觉仿生学
      • 耳仿生学
      • 外骨骼
      • 脑仿生学
      • 心臟瓣膜
      • 心臟仿生学

第七章：市场区隔：依应用

  • 医院
  • 诊所
  • 其他的

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第九章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abiomed
    • BiVACOR Inc
    • CARMAT
    • Cirtec Medical
    • Edwards Lifesciences
    • Ekso Bionics Holdings Inc.
    • Nikkiso Co. Ltd.
    • Second Sight Medical Products Inc
    • SynCardia Systems LLC (Picard Medical Inc.)
Product Code: SR112025A6458

The global artificial vital organs and medical bionics market size reached USD 49.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 74.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.48% during 2025-2033. The rising prevalence of respiratory ailments, cirrhosis, and heart and liver failures, the increasing geriatric population that is highly prone to organ disorders, and various technological advancements represent some of the key factors driving the market.

Artificial vital organs, often referred to as artificial organs or bioartificial organs, are man-made devices designed to mimic the functions of natural organs within the human body. These devices are developed to serve as temporary or permanent replacements for malfunctioning or failed biological organs, helping patients maintain essential bodily functions and, in some cases, even enhancing them. On the other hand, medical bionics is a field of medical science and engineering that focuses on the development and integration of biological and artificial components to restore or enhance the functioning of the human body.

Currently, there is a notable surge in the prevalence of various medical conditions, including respiratory disorders, cirrhosis, as well as heart, kidney, and liver failures. This surge is closely tied to the expanding healthcare sector and serves as a significant catalyst for market growth. Furthermore, the increasing elderly population, which is particularly susceptible to organ-related ailments worldwide, is making a substantial contribution to the market's expansion. Moreover, the continuous development of innovative products, such as fully functional artificial hearts, livers, lungs, urethras, windpipes, and kidneys, is exerting a positive impact on market dynamics. Additionally, major market players are making substantial investments in research and development (R&D) endeavors, aimed at introducing cutting-edge methods of organ regeneration through engineered tissues. This ongoing innovation is fostering a promising outlook for the market. Besides this, there is a rising demand for artificial organs, driven by the emergence of bioartificial organs that offer improved survival rates and faster patient recovery. This growing demand is further propelled by the implementation of life-saving technologies like the bridge to transplant and the bridge to recovery in critical medical cases, further reinforcing market growth.

Artificial Vital Organs and Medical Bionics Market Trends/Drivers:

Rising prevalence of respiratory ailments, cirrhosis, and organ failures

There has been a notable increase in the prevalence of respiratory ailments such as chronic obstructive pulmonary disease (COPD) and lung infections. Patients with severe respiratory issues often require artificial lungs or other assistive devices to breathe adequately. Moreover, liver diseases, including cirrhosis, have seen a rise due to various factors like excessive alcohol consumption, viral hepatitis infections, and non-alcoholic fatty liver disease. In advanced stages, cirrhosis may necessitate liver transplantation, and artificial livers can serve as a bridge to transplantation or even a long-term solution. Besides, heart and liver failures are significant health concerns worldwide. Conditions like congestive heart failure and end-stage liver disease are on the rise due to factors such as an aging population, obesity, and lifestyle choices. Artificial hearts and liver support systems play a crucial role in providing life-saving solutions while patients await transplantation or as a permanent support option.

Increasing geriatric population across the globe

The global demographic landscape is shifting toward an aging population. Elderly individuals are more susceptible to organ disorders due to the natural aging process, making them a key demographic for artificial vital organ interventions. Besides, the elderly population is more prone to chronic medical conditions, including cardiovascular diseases, respiratory ailments, and kidney disorders. These conditions frequently require interventions such as artificial hearts, lungs, or kidneys to manage or improve the patient's quality of life. Medical bionics, such as pacemakers and cochlear implants, are also commonly used in elderly individuals to address age-related health issues. Artificial vital organs and medical bionics become crucial in extending and improving the lives of these elderly individuals, allowing them to enjoy a better quality of life in their later years.

Various technological advancements

Advancements in medical technology have significantly improved the design, functionality, and effectiveness of artificial vital organs and medical bionics. Moreover, full-functioning artificial organs, such as artificial hearts and lungs, have been developed with enhanced capabilities, allowing patients to lead more active lives. Besides, the integration of cutting-edge materials and bioengineering techniques has led to the creation of bioartificial organs that closely mimic natural organs, reducing the risk of rejection and improving overall patient outcomes. Additionally, leading players in the medical technology industry are investing heavily in research and development activities aimed at improving artificial vital organs and medical bionics. These investments result in the development of more sophisticated devices, enhanced materials, and improved surgical techniques, all of which contribute to better patient outcomes.

Key Market Segmentation:

Breakup by Product Type:

  • Artificial Vital Organs
    • Artificial Liver
    • Artificial Heart
    • Artificial Pancreas
    • Artificial Kidney
    • Artificial Lungs
    • Oxygenators
  • Medical Bionics
    • Bionic Limbs
    • Vision Bionics
    • Ear Bionics
    • Exoskeletons
    • Brain Bionics
    • Heart Valves
    • Cardiac Bionics

Artificial vital organs represent the most used product type

Artificial vital organs are designed to mimic the functions of natural vital organs such as the heart, lungs, kidneys, and liver. These devices are often used as a last resort when a patient's natural organs fail. They serve a life-saving function, providing crucial support to sustain a patient's life until a transplant becomes available or the natural organs recover. Moreover, there is a consistently high demand for artificial vital organs due of the prevalence of organ failure and the limited availability of organ donors. Individuals worldwide suffer from conditions that can lead to organ failure, and the demand for replacement organs far exceeds the supply. Artificial vital organs bridge this gap by offering a viable solution to patients in critical need.

Breakup by Application:

  • Hospitals
  • Clinics
  • Others

Hospitals are a primary application for artificial vital organs and medical bionics. In these healthcare facilities, artificial vital organs such as artificial hearts, lungs, and kidneys are often used to support patients with organ failure while they await transplants. Additionally, medical bionics, including devices like cochlear implants and bionic limbs, may be provided to patients in hospital settings to improve their quality of life and functional capabilities.

Clinics, including specialized medical centers and outpatient facilities, play a crucial role in the application of artificial vital organs and medical bionics. These settings are where patients may receive diagnosis, consultation, and follow-up care related to these advanced medical technologies. Clinics often offer services related to the assessment, fitting, and maintenance of medical bionics, making them essential in the continuum of care.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America, particularly the United States and Canada, boasts a highly advanced healthcare infrastructure with state-of-the-art medical facilities and research institutions. This infrastructure fosters innovation and the development of cutting-edge medical technologies, including artificial vital organs and medical bionics. Besides, the region is a global hub for medical research and development. Leading universities, medical centers, and private companies collaborate to push the boundaries of medical science. This collaborative environment accelerates the creation and commercialization of medical bionics and artificial vital organs. Moreover, the region has well-established regulatory bodies, such as the Food and Drug Administration (FDA) in the United States and Health Canada, which ensure the safety and efficacy of medical devices. A robust regulatory framework provides confidence to investors, manufacturers, and healthcare providers, encouraging the development and adoption of medical bionics.

Competitive Landscape:

The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are heavily investing in R&D to develop innovative and advanced artificial vital organs and medical bionics. They focus on improving the performance, durability, and safety of these devices, as well as reducing their size and enhancing compatibility with the human body. They are also expanding their product portfolios to cover a broader range of medical bionics and artificial organs. This diversification allows them to address a wider array of medical conditions and patient needs. Besides, companies are acquiring or merging with other companies in the industry to expand capabilities, gain access to new technologies, and increase market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abiomed
  • BiVACOR Inc
  • CARMAT
  • Cirtec Medical
  • Edwards Lifesciences
  • Ekso Bionics Holdings Inc.
  • Nikkiso Co. Ltd.
  • Second Sight Medical Products Inc
  • SynCardia Systems LLC (Picard Medical Inc.)

Key Questions Answered in This Report

  • 1.How big is the artificial vital organs and medical bionics market?
  • 2.What is the expected growth rate of the global artificial vital organs and medical bionics market during 2025-2033?
  • 3.What are the key factors driving the global artificial vital organs and medical bionics market?
  • 4.What has been the impact of COVID-19 on the global artificial vital organs and medical bionics market?
  • 5.What is the breakup of the global artificial vital organs and medical bionics market based on the product type?
  • 6.What are the key regions in the global artificial vital organs and medical bionics market?
  • 7.Who are the key players/companies in the global artificial vital organs and medical bionics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Vital Organs and Medical Bionics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Artificial Vital Organs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Artificial Liver
      • 6.1.2.2 Artificial Heart
      • 6.1.2.3 Artificial Pancreas
      • 6.1.2.4 Artificial Kidney
      • 6.1.2.5 Artificial Lungs
      • 6.1.2.6 Oxygenators
    • 6.1.3 Market Forecast
  • 6.2 Medical Bionics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bionic Limbs
      • 6.2.2.2 Vision Bionics
      • 6.2.2.3 Ear Bionics
      • 6.2.2.4 Exoskeletons
      • 6.2.2.5 Brain Bionics
      • 6.2.2.6 Heart Valves
      • 6.2.2.7 Cardiac Bionics
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abiomed
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BiVACOR Inc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 CARMAT
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cirtec Medical
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Edwards Lifesciences
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Ekso Bionics Holdings Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Nikkiso Co. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Second Sight Medical Products Inc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 SynCardia Systems LLC (Picard Medical Inc.)
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Artificial Vital Organs and Medical Bionics Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: North America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: North America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: United States: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: United States: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Canada: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Canada: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: China: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: China: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Japan: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Japan: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: India: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: India: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: South Korea: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: South Korea: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Australia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Australia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Indonesia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Indonesia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Europe: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Europe: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Germany: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Germany: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: France: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: France: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United Kingdom: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United Kingdom: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Italy: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Italy: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Spain: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Spain: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Russia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Russia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Latin America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Latin America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Brazil: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Brazil: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Mexico: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Mexico: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Breakup by Country (in %), 2024
  • Figure 65: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Global: Artificial Vital Organs and Medical Bionics Industry: SWOT Analysis
  • Figure 67: Global: Artificial Vital Organs and Medical Bionics Industry: Value Chain Analysis
  • Figure 68: Global: Artificial Vital Organs and Medical Bionics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Vital Organs and Medical Bionics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Artificial Vital Organs and Medical Bionics Market: Competitive Structure
  • Table 6: Global: Artificial Vital Organs and Medical Bionics Market: Key Players